Stealth BioTherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, known as the powerhouse of the cell, are critical for normal organ function. Stealth's lead candidate, elamipretide, is being investigated for various rare mitochondrial diseases and other conditions with high unmet medical needs. The company aims to improve the lives of patients suffering from these debilitating conditions by targeting the underlying mitochondrial impairment.
Serves as the main U.S. operational base, overseeing clinical development programs, research collaborations, regulatory affairs, and corporate administration.
Modern office space situated in a commercial building in Hudson Square, a neighborhood known for its mix of tech, media, and life science companies. Proximity to academic research institutions and a vibrant biotech ecosystem.
A focused, science-driven, and collaborative environment. Employees are typically passionate about addressing rare diseases and driven by a patient-centric mission. As a smaller, specialized biotech, agility and innovation are key aspects of the culture.
The New York headquarters centralizes Stealth BioTherapeutics' U.S. operations, facilitating strategic decision-making and management of its clinical programs aimed at tackling mitochondrial diseases.
Stealth BioTherapeutics primarily conducts its research and development operations from its U.S. base. Its global presence is mainly characterized by its clinical trial activities, which may involve sites and patients in multiple countries to evaluate the efficacy and safety of its drug candidates. The company also engages with the international scientific and medical community through publications, conference presentations, and collaborations with research institutions worldwide. While its physical office footprint is concentrated, its impact and reach in the field of mitochondrial medicine are global.
180 Varick Street, Suite 812
New York
NY
USA
Address: Clarendon House, 2 Church Street, HM 11
Legal and corporate registration in an international financial center. Not an active R&D or primary business operations site.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Stealth BioTherapeutics' leadership includes:
Stealth BioTherapeutics has been backed by several prominent investors over the years, including:
Following its transition to a private company in late 2022/early 2023, there have been no major publicly announced executive team changes in the last 12 months. Leadership stability under CEO Reenie McCarthy has been maintained. Detailed information on internal team adjustments is not publicly available.
Discover the tools Stealth BioTherapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Stealth BioTherapeutics likely utilizes a common corporate email format. Based on publicly available information for some executives, one observed pattern is the first initial followed by the last name.
[first_initial][last]@stealthbt.com
Format
jsmith@stealthbt.com
Example
75%
Success rate
Stealth BioTherapeutics Website • May 2, 2024
Stealth BioTherapeutics announced new data presentations on elamipretide at the Mitochondrial Medicine 2024 Symposium, hosted by the United Mitochondrial Disease Foundation. The presentations highlighted findings relevant to the treatment of primary mitochondrial disease....more
Stealth BioTherapeutics Website • January 25, 2023
The company announced the publication of data from its Phase 2 ReCLAIM-2 trial in the Journal of Clinical Investigation. The trial evaluated the safety and efficacy of elamipretide in patients with dry age-related macular degeneration (AMD) with noncentral geographic atrophy and high-risk drusen....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Stealth BioTherapeutics, are just a search away.